The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19

J Am Heart Assoc. 2020 Sep 15;9(18):e018274. doi: 10.1161/JAHA.120.018274. Epub 2020 Jul 27.
No abstract available

Keywords: COVID‐19; biomarker; clinical trial; renin-angiotensin system; troponin.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / therapy*
  • Clinical Trials as Topic / methods*
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / therapy
  • Coronavirus Infections* / virology
  • Host-Pathogen Interactions
  • Humans
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / therapy
  • Pneumonia, Viral* / virology
  • Research Design*
  • SARS-CoV-2
  • Time Factors
  • United States / epidemiology